Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments

ConclusionMajor changes of PD-L1 expression in tumor cells were observed in 38% of NSCLC patients who received anticancer treatments. And, treatments with EGFR-TKI may increase PD-L1 expression in NSCLC patients harboringEGFR mutations.

Source: International Journal of Clinical Oncology - June 15, 2018 Category: Cancer & Oncology Source Type: research